In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Amneal trades above its PERT fair value of $16.43, indicating potential overvaluation with a -14.3% implied downside. Mixed valuation methods show wide price targets ($4.18 to $43.60), reflecting high uncertainty. Strong liquidity and growth contrast sharp profitability and efficiency weaknesses, while Monte Carlo reveals notable volatility and 58.3% downside risk beneath current price.